(Comm. by Tanemoto FURUHATA, M.J.A., Dec. 13, 1965) By means of an ability to inhibit the agglutination that occurs between sera from some cases of rheumatoid arthritis and Rh-positive red cells sensitized with an incomplete anti-D (anti-Rho), Grubbl} defined a new serum factor carried by the 7-globulins, the Gm(a) factor.
Several such factors including Gm(b) [Gm(ba), Gm(b8) Gm(b7); Gm(b1) Gm(b2) Gm(b3) Gm(b4)1 , Gm(x), Gm(c) (Gm-like), Gm(f ), Gm(d) (GmDresden Gm(D)), Gm(e), Gm(p), Gm(r), Inv(a), Inv(b), and Inv(1) have so far been discovered.
To obtain anti-Rh and anti-Gm sera capable of testing Gm factors from the Japanese, Rh positive cells sensitized with 6 anti-D sera were cross-reacted with about 300 sera from rheumatoid arthritis patients. Cells sensitized with two anti-D sera (Mr. T. Negishi and Mrs. S. Yokoo) were strongly agglutinated with a rheumatoid serum (Mrs. T. Miyamoto).
This reaction was inhibited remarkably by one group of normal Japanese sera, but only weakly inhibited by an other group.
The specificity was apparently different from these of Gm groups which have been far reported and this Gm factor was tentatively named Gm(m). The present paper is concerned with the Gm(m) factor. Agglutination inhibition tests. The tests were performed on slides at room temperature using one drop of each reagent. (a) Sensitization of red cells with an anti-D serum and titration of anti-Gm(m).
One volume of 20% suspension of washed, packed 0, Rh positive cells was mixed with an equal volume of incomplete anti-Rh serum Negishi diluted 1: 5 in saline. After incubation at 37°C for 1 hour, the cells were washed thoroughly and an 0.3% suspension of the sensitized cells was prepared.
One drop of each of serial twofold dilutions of rheumatoid serum Miyamoto and one drop of the suspension of coated cells were mixed. The results of the agglutination were observed after 30 minutes and the agglutinating titer of 1:10240 was obtained for the anti-Gm(m) serum. The serum did not show a prozone.
(b) Two dimensional titration.
Six normal sera were tested, among which two Gm(m +) and four Gm(m -) sera with various combination of Gm(b), Gm(x), Inv(a), and Inv(b) factors were included. These sera were serially twofold diluted 1: 2 to 1:1024 and anti-Gm(m) serum Miyamoto was similarly diluted 1: 2 to 1: 512. Each dilution of the 6 normal and of the anti-Gm(m) sera were cross-reacted for 15 minutes.
Then the suspension of sensitized cells was added to the mixture.
The agglutination of each mixture was graded 5, 4, 3, 2, 1, and 0; the respective scores of each reaction for a serial dilution of a serum or anti-Gm(m) were added and an agglutination inhibition score was obtained.
The reaction patterns are shown in Fig. 1 ; results of titrations of normal sera are shown in Fig. 1(a) and those of anti-Gm(m) Miyamoto are in Fig. 1(b) . These figures indicate that the inhibition curves of Gm(m +) and Gm(m --) sera are quite different.
Sharp definition was obtained by titration of normal sera as well as anti-Gm(m) serum, but the former was preferably used in the experiment because the quantity of anti-Gm(m) serum was limited.
(c) Agglutination inhibition titer of normal sera. To each of serially twofold diluted normal sera was added anti-Gm(m) Miyamoto diluted 1; 40 in saline.
Then the suspension of sensitized cells was added. The results on 6 normal sera are shown in Table I . Strong inhibition is seen in two of these sera (Y. Fukumizu and R. Iiji), while the other four show weak inhibition.
The distribution of agglutination inhibition scores on 127 normal Japanese is shown in Fig. 2 . Two separate curves were obtained.
The lower rejection limit of the curve of Gm(m-) is 13.6 and the upper rejection limit of Gm(m +) is 5.9 if each curve is regarded as normal, indicating that the Gm(m +) group is different from Gm(m -) group.
(d) Routine tests.
Normal human sera diluted 1:20 were employed instead of serial dilutions in routine tests.
One drop of diluted normal serum and one drop of anti-Gm(m) Miyamoto diluted 1; 40 were mixed.
After incubation the suspension of coated cells was added. In most tests, anti-D Negishi was used to sensitize the cells, but the same results were also obtained with anti-D Yokoo.
Donors o f anti-Gm(m) and anti-Rh sera. Mrs. Miyamoto, the donor of anti-Gm(m) serum, died at 40 years of age from liposarcoma of the right leg with abdominal metastasis followed by generalized weakness.
She had also suffered from rheumatoid arthritis for seven years prior to her death. She had syphilitic anamnesis and her wasserman reaction was positive.
Mr. Negishi is a healthy adult whose anti-D was stimulated by transfusion. He has occasionally been given Rh positive cells (cDE/cDE) to obtain antiserum for Rh typings.
Once he was given CDe/CDe blood by mistake instead of cDE/cDE, and anti-C antibody was produced as well. The anti-C antibody disappeared in his serum after a few months and could not be reproduced afterwards by immunization with cDE/cDE blood. The ability to sensitize Rh positive cells for Gm (m) tests was lost from his serum during the period when anti-C antibody was present.
The ability was recovered as the anti-C antibody disappeared.
The anti-D antibody of Mrs. Yokoo who was 0, Rh negative (ccddee), was found in her serum after her third pregnancy.
Her last two pregnancies were uneventful. Her fifth infant died in utero and her serum lost the ability to sensitize cells for Gm(m) tests afterwards.
Racial survey on Gm(m) factor. The frequency of Gm(m) factor in the Japanese (Tokyo), Thais, Negroes (New York), and Whites (New York and Yokosuka) are shown in Table II .
The frequencies of Gm(m+) are similar among the Japanese, Thais and American Whites (Japanese-Thais: x2= 0.42, 0.5<p< 0.8; Japanese-American Whites: x2=0.0025, 0.95<p<0.98), while the Negroes have a higher frequency than the other populations tested (JapaneseNegroes: x2=37.3, p<0.0o1).
There appeared no relationship between sex and Gm(m) type (for Japanese, x2 = 0.0023, 0.95<p< 0.98).
Specificity of Gm(m) factor. The anti-Gm serum was Gm (a+ b -c -) Inv(a -), Gm(b), Gm(c), and Inv(a) may be involved in Gm(m) system.
However, the anti-Rh sera of Mr. Negishi and Mrs. Yokoo were grouped as Gm(a + b -x + c -e -) Inv(a + b + 1+) and Gm(a + xe-) Inv(a + l +) respectively, indicating that the Gm(b), Gm(x), Gm(c), and Gm(e) factors are not involved in inhibition of the Gm(m) system, 
Gm(m) and the other Gm factors on 8 normal Japanese
The Gm(m) factor shows different specificity than Gm(a), (b), (x), (c), (e), (r), Inv(a), (b), and (1) as indicated in Table III . The frequencies of Gm(m +) among the Caucasians (8,8%) are quite different from those of Gm(d +) (64,8% among 1000 sub jects)3' (2=163.3, xp<0.001) and Gm(p +) (86.8% among 129 sub jects)4' (x2= 169.3, p < 0.001). It seems probable that Gm(m) has different specificity from other known Gm factors.
Immuno-chemical nature of anti-Gm(m) and Gm(m) factor. It has been demonstrated that the agglutinating activity of rheumatoid sera, regardless of specificity, is associated with IgM.S' The distribution of the Gm(m) activity among the serum fractions was tested.
The anti-Gm(m) activity was destroyed after heating at 63°C for 15 minutes6' or treatment with mercaptoethanol.7' This indicates that the activity of anti-Gm(m) is also restricted to IgM.
The Gm(a), Gm(b), Gm(x)8', and Gm(p)4~ characters were found only on the Fc(F) fragment of IgG obtained by papain digestion in the presence of cysteine, while Inv(a) and Inv(b)g' characters were found on all classes of immuno-globulin and on the Fab(S) fragment in the case of IgG. The occurence of the Gm(m) factor on serum proteins and their subunits was studied.
Gm(m +) and Gm(m -) sera were fractionated into the albumin, a, /9, and 7-globulins by DEAEchromatography and it was revealed that the inhibitory activity was confined to the 7-globulin fraction of the serum proteins. These human sera were treated with Sephadex G 20010' and the IgM and IgG fractions were obtained.
Only the IgG fraction shows Gm(m) activity.
Commercial preparation of Cohn fraction II, which was manufactured in Nihon Seiyaku Co. Ltd, from about a hundred pooled human plasma, showed inhibitory activity.
Fraction II was digested with papain to obtain Fab and Fc f ragments.10'
The Gm(m) activity was detected only in the Fc fragment.
This also showed that the activity apparently was on the H (A) chain. All the tests were performed not only on the Gm(m) factor alone but also on the Gm(a) factor.
The activity of both factors was always present in the same fraction.
G(m)m inhibitory activity of saliva and seminal fluid. Gm(a) activity was shown in seminal fluid of secretor" or spermatozoa but not in saliva.12' Three salival samples from Gm(m+) Se individuals were tested for Gm(m) activity, but they did not inhibit the reaction at all. Same test was performed on seminal fluid obtained from one Gm(m +) Se and three Gm(m --) individuals, and the former showed strong inhibiting activity but the latter scarcely inhibited. The inhibiting activity of the seminal fluid was about one [Vol. 41,  sixteenth of that of the serum of same individual, Immunization experiment with Gm(m+) sera. Since anti-Gm and anti-Iv have been experimentally produced in the rhesus monkey13',14' and in humans15, "6, immunized with human gamma globulin, a Japanese monkey and five rabbits were immunized with a commercial preparation of fraction II which showed Gm(m) activity.
15 mg of fraction II dissolved in 3 ml of saline was mixed with 3 ml of complete Freund's adjuvant and given intramusculary four times at three week intervals. Anti-Gm activity could not be demonstrated.
Studies on heredity and linkage to other serum groups of Gm(m) are not completed.
